CA2627741A1 - Pointe de catheter optique rotative destinee a une tomographie par coherence optique - Google Patents
Pointe de catheter optique rotative destinee a une tomographie par coherence optique Download PDFInfo
- Publication number
- CA2627741A1 CA2627741A1 CA002627741A CA2627741A CA2627741A1 CA 2627741 A1 CA2627741 A1 CA 2627741A1 CA 002627741 A CA002627741 A CA 002627741A CA 2627741 A CA2627741 A CA 2627741A CA 2627741 A1 CA2627741 A1 CA 2627741A1
- Authority
- CA
- Canada
- Prior art keywords
- conduit
- fluid
- rotating
- tip assembly
- turbine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000003287 optical effect Effects 0.000 title claims description 17
- 238000012014 optical coherence tomography Methods 0.000 title abstract description 28
- 239000012530 fluid Substances 0.000 claims abstract description 61
- 239000013307 optical fiber Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 14
- 208000000260 Warts Diseases 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 12
- 201000010153 skin papilloma Diseases 0.000 claims description 12
- 238000003384 imaging method Methods 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 239000002473 artificial blood Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000001307 helium Substances 0.000 claims description 2
- 229910052734 helium Inorganic materials 0.000 claims description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 239000001569 carbon dioxide Substances 0.000 claims 1
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 1
- 239000004973 liquid crystal related substance Substances 0.000 claims 1
- 239000000835 fiber Substances 0.000 abstract description 11
- 210000004351 coronary vessel Anatomy 0.000 description 11
- 239000007789 gas Substances 0.000 description 8
- 210000001519 tissue Anatomy 0.000 description 8
- 208000010125 myocardial infarction Diseases 0.000 description 6
- 239000003633 blood substitute Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 150000002632 lipids Chemical group 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- 206010000891 acute myocardial infarction Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000002540 macrophage Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 238000002586 coronary angiography Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 238000002608 intravascular ultrasound Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
- 239000004926 polymethyl methacrylate Substances 0.000 description 2
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 2
- 208000004476 Acute Coronary Syndrome Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002388 Angina unstable Diseases 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010042434 Sudden death Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- UBAZGMLMVVQSCD-UHFFFAOYSA-N carbon dioxide;molecular oxygen Chemical compound O=O.O=C=O UBAZGMLMVVQSCD-UHFFFAOYSA-N 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 108010037743 hemoglobin glutamer-200 Proteins 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000002966 stenotic effect Effects 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By Optical Means (AREA)
- Endoscopes (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/548,982 US7711413B2 (en) | 2003-04-28 | 2004-04-23 | Catheter imaging probe and method |
| US72848105P | 2005-10-20 | 2005-10-20 | |
| US60/728,481 | 2005-10-20 | ||
| US10/548,982 | 2006-05-02 | ||
| PCT/US2006/041125 WO2007047974A2 (fr) | 2005-10-20 | 2006-10-20 | Pointe de catheter optique rotative destinee a une tomographie par coherence optique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2627741A1 true CA2627741A1 (fr) | 2007-04-26 |
Family
ID=39672000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002627741A Abandoned CA2627741A1 (fr) | 2005-10-20 | 2006-10-20 | Pointe de catheter optique rotative destinee a une tomographie par coherence optique |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2010504762A (fr) |
| CN (1) | CN101415366A (fr) |
| CA (1) | CA2627741A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108882857A (zh) * | 2016-01-25 | 2018-11-23 | 阿维格公司 | 具有滞后修正的oct成像导管 |
| US11547314B2 (en) * | 2017-11-28 | 2023-01-10 | Dotter Inc. | Optical coherence tomography system |
-
2006
- 2006-10-20 CA CA002627741A patent/CA2627741A1/fr not_active Abandoned
- 2006-10-20 JP JP2008536839A patent/JP2010504762A/ja not_active Withdrawn
- 2006-10-20 CN CNA2006800482756A patent/CN101415366A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010504762A (ja) | 2010-02-18 |
| CN101415366A (zh) | 2009-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7853316B2 (en) | Rotating optical catheter tip for optical coherence tomography | |
| AU2004233872C1 (en) | Catheter imaging probe and method | |
| US9254102B2 (en) | Method and apparatus for imaging of vessel segments | |
| US8401610B2 (en) | Rotating catheter probe using a light-drive apparatus | |
| CA2627741A1 (fr) | Pointe de catheter optique rotative destinee a une tomographie par coherence optique | |
| Feldman et al. | Rotating optical catheter tip for optical coherence tomography | |
| ITeldman et al. | Milner et al. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued | ||
| FZDE | Discontinued |
Effective date: 20121022 |